Eupraxia Pharmaceuticals closes $80.5-million offering
Eupraxia Pharmaceuticals closes $80.5-million offering
Healthcare
Page 126- Sep 24, 2025 · 18:03 · QNTM01
Quantum Biopharma licensee Unbuzzd to host webinar
Quantum Biopharma licensee Unbuzzd to host webinar
- Sep 24, 2025 · 16:43 · TLT02
Theralase's ruvidar shown effective for herpes simplex
Theralase's ruvidar shown effective for herpes simplex
- Sep 24, 2025 · 12:05 · THRM03
Therma Bright expands Venowave sales with Gen-X Med
Therma Bright expands Venowave sales with Gen-X Med
- Sep 23, 2025 · 20:08 · HELP04
Cybin plans to enroll 220 participants for CYB003 study
Cybin plans to enroll 220 participants for CYB003 study
- Sep 23, 2025 · 18:58 · HEM05
Hemostemix files FDA trial for ACP-01 stem therapy
Hemostemix files FDA trial for ACP-01 stem therapy
- Sep 23, 2025 · 17:45 · PRN06
Profound Medical talks Tulsa use by Texas Prostate
Profound Medical talks Tulsa use by Texas Prostate
- Sep 23, 2025 · 17:09 · AIDR07
Rocket Doctor AI in network with Maryland Medicaid
Rocket Doctor AI in network with Maryland Medicaid
- Sep 23, 2025 · 12:03 · MBX08
Microbix aids EMQN on genetic-test dosing program
Microbix aids EMQN on genetic-test dosing program
- Sep 23, 2025 · 10:14 · NARA09
Pangenomic selects Hong Kong for health AI centre site
Pangenomic selects Hong Kong for health AI centre site
- Sep 23, 2025 · 06:36 · EPRX10
Eupraxia prices shares of offering at $5.50 (U.S.)
Eupraxia prices shares of offering at $5.50 (U.S.)
- Sep 23, 2025 · 06:22 · VST11
Victory Square to buy back up to five million shares
Victory Square to buy back up to five million shares
- Sep 22, 2025 · 21:34 · EPRX12
Eupraxia files preliminary prospectus for offering
Eupraxia files preliminary prospectus for offering
- Sep 22, 2025 · 17:50 · AIAI13
Netramark launches AI glioblastoma research collab
Netramark launches AI glioblastoma research collab
- Sep 22, 2025 · 17:01 · APS14
Aptose enters $11.9M (U.S.) amended loan facility
Aptose enters $11.9M (U.S.) amended loan facility